EFFICACY AND SAFETY OF RIVAROXABAN IN REDUCING THE RISK OF MAJOR THROMBOTIC VASCULAR EVENTS IN SUBJECTS WITH SYMPTOMATIC PERIPHERAL ARTERY DISEASE UNDERGOING PERIPHERAL REVASCULARIZATION PROCEDURES OF THE LOWER EXTREMITIES: